1. Home
  2. CPIX vs AERT Comparison

CPIX vs AERT Comparison

Compare CPIX & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • AERT
  • Stock Information
  • Founded
  • CPIX 1999
  • AERT 2012
  • Country
  • CPIX United States
  • AERT Singapore
  • Employees
  • CPIX N/A
  • AERT N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • AERT Professional Services
  • Sector
  • CPIX Health Care
  • AERT Consumer Discretionary
  • Exchange
  • CPIX Nasdaq
  • AERT Nasdaq
  • Market Cap
  • CPIX 68.7M
  • AERT 25.4M
  • IPO Year
  • CPIX 2009
  • AERT N/A
  • Fundamental
  • Price
  • CPIX $5.15
  • AERT $0.54
  • Analyst Decision
  • CPIX
  • AERT
  • Analyst Count
  • CPIX 0
  • AERT 0
  • Target Price
  • CPIX N/A
  • AERT N/A
  • AVG Volume (30 Days)
  • CPIX 4.2M
  • AERT 72.5K
  • Earning Date
  • CPIX 03-04-2025
  • AERT 02-24-2025
  • Dividend Yield
  • CPIX N/A
  • AERT N/A
  • EPS Growth
  • CPIX N/A
  • AERT N/A
  • EPS
  • CPIX N/A
  • AERT N/A
  • Revenue
  • CPIX $36,785,442.00
  • AERT $72,141,000.00
  • Revenue This Year
  • CPIX N/A
  • AERT N/A
  • Revenue Next Year
  • CPIX N/A
  • AERT N/A
  • P/E Ratio
  • CPIX N/A
  • AERT N/A
  • Revenue Growth
  • CPIX N/A
  • AERT 16.98
  • 52 Week Low
  • CPIX $1.04
  • AERT $0.51
  • 52 Week High
  • CPIX $6.43
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 68.22
  • AERT 36.05
  • Support Level
  • CPIX $4.12
  • AERT $0.55
  • Resistance Level
  • CPIX $5.29
  • AERT $0.66
  • Average True Range (ATR)
  • CPIX 0.74
  • AERT 0.10
  • MACD
  • CPIX 0.17
  • AERT -0.00
  • Stochastic Oscillator
  • CPIX 70.57
  • AERT 9.81

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: